1.Risk factors for Crohn's disease-like pouch in ulcerative colitis patients with ileal pouch-anal anastomosis
Yinan YAN ; Juan WEI ; Zhao YANG ; Ya YANG ; Hui TAO ; Liuying LI ; Hongqin WANG ; Yuanyi ZHAO ; Feng ZHU ; Ji XUAN ; Jianfeng GONG ; Fangyu WANG
Chinese Journal of Inflammatory Bowel Diseases 2025;09(3):211-217
Objective:To explore the incidence of Crohn's disease-like pouch (CDP) after ileal pouch-anal anastomosis (IPAA) and analyze the clinical characteristics and risk factors in ulcerative colitis (UC) patients.Methods:A retrospective cohort study was conducted. One hundred and eighty-two UC patients undergoing IPAA at Jinling Hospital affiliated to Nanjing University from November 2003 to November 2024 were enrolled. Patients were categorized into CDP and non-CDP groups. Clinical features and prognosis were compared, and multivariate Cox regression was performed to identify risk factors for CDP.Results:A total of 182 UC patients were included, with a median follow-up time of 45.00 (30.00, 75.25) months. The patients were divided into two groups based on the diagnosis of CDP, with 23 patients (12.64%) in the CDP group and 159 patients (87.30%) in the non-CDP group. Compared to the non-CDP group, patients in the CDP group had a lower body mass index (BMI) ( Z=-2.87, P=0.004), and were more likely to develop early postoperative pouchitis (χ 2=4.50, P=0.034). The median time from ileostomy closure to the development of CDP was 12 .00 (6.00, 28.00) months. Cox regression analysis showed that a preoperative BMI<18.5 kg/m 2 ( HR=2.84, 95% CI: 1.24~6.49, P=0.013) and early postoperative pouchitis ( HR=3.11, 95% CI: 1.22~7.93, P=0.018) were associated with an increased risk of CDP. Conclusions:Preoperative low BMI and pouchitis occurring within 3 months postoperatively are significant risk factors for CDP. Close monitoring and early intervention are recommended for high-risk patients.
2.Risk factors for Crohn's disease-like pouch in ulcerative colitis patients with ileal pouch-anal anastomosis
Yinan YAN ; Juan WEI ; Zhao YANG ; Ya YANG ; Hui TAO ; Liuying LI ; Hongqin WANG ; Yuanyi ZHAO ; Feng ZHU ; Ji XUAN ; Jianfeng GONG ; Fangyu WANG
Chinese Journal of Inflammatory Bowel Diseases 2025;09(3):211-217
Objective:To explore the incidence of Crohn's disease-like pouch (CDP) after ileal pouch-anal anastomosis (IPAA) and analyze the clinical characteristics and risk factors in ulcerative colitis (UC) patients.Methods:A retrospective cohort study was conducted. One hundred and eighty-two UC patients undergoing IPAA at Jinling Hospital affiliated to Nanjing University from November 2003 to November 2024 were enrolled. Patients were categorized into CDP and non-CDP groups. Clinical features and prognosis were compared, and multivariate Cox regression was performed to identify risk factors for CDP.Results:A total of 182 UC patients were included, with a median follow-up time of 45.00 (30.00, 75.25) months. The patients were divided into two groups based on the diagnosis of CDP, with 23 patients (12.64%) in the CDP group and 159 patients (87.30%) in the non-CDP group. Compared to the non-CDP group, patients in the CDP group had a lower body mass index (BMI) ( Z=-2.87, P=0.004), and were more likely to develop early postoperative pouchitis (χ 2=4.50, P=0.034). The median time from ileostomy closure to the development of CDP was 12 .00 (6.00, 28.00) months. Cox regression analysis showed that a preoperative BMI<18.5 kg/m 2 ( HR=2.84, 95% CI: 1.24~6.49, P=0.013) and early postoperative pouchitis ( HR=3.11, 95% CI: 1.22~7.93, P=0.018) were associated with an increased risk of CDP. Conclusions:Preoperative low BMI and pouchitis occurring within 3 months postoperatively are significant risk factors for CDP. Close monitoring and early intervention are recommended for high-risk patients.
3.Mechanisms of paeoniflorin in treating hyperprolactinemia based on gut microbiota and metabolomics
Bingqi LIN ; Yuanyi WEI ; Yun YI ; Chunxia WANG
China Pharmacy 2025;36(13):1610-1616
OBJECTIVE To investigate the mechanisms of paeoniflorin(PF)in anti-hyperprolactinemia(HPRL).METHODS Twenty-four female SD rats were divided into blank control group(intragastric administration of 5%gum arabic solution),olanzapine group(model group,intragastric administration of 5 mg/kg olanzapine suspension),and PF group(intragastric administration of 5 mg/kg olanzapine suspension,followed by gavaging with 50 mg/kg PF solution 2 hours later)with 8 rats in each group.Once a day,continuously model/administer until the plasma prolactin(PRL)levels in the olanzapine group were twice as high as those in the blank control group.PRL levels were measured.The changes in gut microbiota of rats were analyzed,including assessments of α-diversity(Simpson,Chao1,and Shannon indexes),β-diversity,species composition analysis(at the phylum and genus levels),and microbiome LEfSe analysis.Fecal untargeted metabolomics technology was employed to analyze the effects of PF on the fecal metabolomics of rats,including multivariate statistical analysis,screening of differential metabolites,and pathway enrichment analysis.Spearman correlation analysis was performed to examine the correlations between differential microbiota and differential fecal metabolites.RESULTS PF significantly reduced serum PRL levels of rats in olanzapine group(P<0.05).16S rRNA sequencing revealed that PF improved the α-diversity and β-diversity of gut microbiota in HPRL rats(P<0.05),restoring them to levels similar to the blank control group.At the phylum level,PF significantly reduced the relative abundance of Firmicutes and Desulfobacterota,while increasing the relative abundance of Verrucomicrobiota in HPRL rats(all P<0.05).At the genus level,PF reversed the relative abundance of Desulfovibrio,Allobaculum,and Prevotellaceae_NK3B31_group,etc(all P<0.05).The results of LEfSe analysis revealed that PF significantly enriched microbial taxa such as Actinobacteriota,Staphylococcales,Corynebacteriales,etc(all P<0.05).Metabolomics analysis identified 51 differential metabolites,with key metabolic pathways enriched in steroid hormone biosynthesis,prostate cancer,ovarian steroidogenesis,etc.Correlation analysis showed that the relative abundance of gut microbiota such as Desulfovibrio and Aerococcus was significantly correlated with the levels of steroid hormone metabolites such as tetrahydrocortisol and adrenosterone(P<0.05).CONCLUSIONS PF alleviates PRL by modulating gut microbiota structure in HPRL rats(including significantly reducing the relative abundance of Desulfovibrio,Allobaculum and Aerococcus,as well as significantly increasing the relative abundance of Ruminococcaceae_UBA1819 and Muribaculum),and regulating steroid hormone pathways,then exerting its anti-HPRL effect.
4.Incorporating Insights from Japan's Health Insurance Fund Regulation into China's Framework
Yuhao WANG ; Yuanyi WU ; Jieying HUANG ; Yuqi GU ; Jialong WANG ; Nana LU ; Wei XU
Chinese Health Economics 2024;43(11):91-96
Objective:To introduce the health insurance fund supervision model in Japan,compare the current situation of health insurance fund supervision in China,learn from experiences,and propose suggestions for improvement.Methods:By combining cases and regulatory effects,it introduces Japan's"guidance-inspection"based health insurance fund supervision model.Results:Japan's"guidance-inspection"based health insurance fund supervision model is relatively effective.Compared with China,it has a higher level of organizational hierarchy,focuses on education in its supervisory approach,clarifies the direction of patients'self-paid expences,and has a well-developed dual-way communication mechanism.Conclusion:China should establish a comprehensive health insurance fund supervision pathway,clearly define the resolution pathway for self-paid expenses caused by violations,and improve the mechanisms for negotiation and dispute resolution during the process.
5.Incorporating Insights from Japan's Health Insurance Fund Regulation into China's Framework
Yuhao WANG ; Yuanyi WU ; Jieying HUANG ; Yuqi GU ; Jialong WANG ; Nana LU ; Wei XU
Chinese Health Economics 2024;43(11):91-96
Objective:To introduce the health insurance fund supervision model in Japan,compare the current situation of health insurance fund supervision in China,learn from experiences,and propose suggestions for improvement.Methods:By combining cases and regulatory effects,it introduces Japan's"guidance-inspection"based health insurance fund supervision model.Results:Japan's"guidance-inspection"based health insurance fund supervision model is relatively effective.Compared with China,it has a higher level of organizational hierarchy,focuses on education in its supervisory approach,clarifies the direction of patients'self-paid expences,and has a well-developed dual-way communication mechanism.Conclusion:China should establish a comprehensive health insurance fund supervision pathway,clearly define the resolution pathway for self-paid expenses caused by violations,and improve the mechanisms for negotiation and dispute resolution during the process.
6.Incorporating Insights from Japan's Health Insurance Fund Regulation into China's Framework
Yuhao WANG ; Yuanyi WU ; Jieying HUANG ; Yuqi GU ; Jialong WANG ; Nana LU ; Wei XU
Chinese Health Economics 2024;43(11):91-96
Objective:To introduce the health insurance fund supervision model in Japan,compare the current situation of health insurance fund supervision in China,learn from experiences,and propose suggestions for improvement.Methods:By combining cases and regulatory effects,it introduces Japan's"guidance-inspection"based health insurance fund supervision model.Results:Japan's"guidance-inspection"based health insurance fund supervision model is relatively effective.Compared with China,it has a higher level of organizational hierarchy,focuses on education in its supervisory approach,clarifies the direction of patients'self-paid expences,and has a well-developed dual-way communication mechanism.Conclusion:China should establish a comprehensive health insurance fund supervision pathway,clearly define the resolution pathway for self-paid expenses caused by violations,and improve the mechanisms for negotiation and dispute resolution during the process.
7.Incorporating Insights from Japan's Health Insurance Fund Regulation into China's Framework
Yuhao WANG ; Yuanyi WU ; Jieying HUANG ; Yuqi GU ; Jialong WANG ; Nana LU ; Wei XU
Chinese Health Economics 2024;43(11):91-96
Objective:To introduce the health insurance fund supervision model in Japan,compare the current situation of health insurance fund supervision in China,learn from experiences,and propose suggestions for improvement.Methods:By combining cases and regulatory effects,it introduces Japan's"guidance-inspection"based health insurance fund supervision model.Results:Japan's"guidance-inspection"based health insurance fund supervision model is relatively effective.Compared with China,it has a higher level of organizational hierarchy,focuses on education in its supervisory approach,clarifies the direction of patients'self-paid expences,and has a well-developed dual-way communication mechanism.Conclusion:China should establish a comprehensive health insurance fund supervision pathway,clearly define the resolution pathway for self-paid expenses caused by violations,and improve the mechanisms for negotiation and dispute resolution during the process.
8.Incorporating Insights from Japan's Health Insurance Fund Regulation into China's Framework
Yuhao WANG ; Yuanyi WU ; Jieying HUANG ; Yuqi GU ; Jialong WANG ; Nana LU ; Wei XU
Chinese Health Economics 2024;43(11):91-96
Objective:To introduce the health insurance fund supervision model in Japan,compare the current situation of health insurance fund supervision in China,learn from experiences,and propose suggestions for improvement.Methods:By combining cases and regulatory effects,it introduces Japan's"guidance-inspection"based health insurance fund supervision model.Results:Japan's"guidance-inspection"based health insurance fund supervision model is relatively effective.Compared with China,it has a higher level of organizational hierarchy,focuses on education in its supervisory approach,clarifies the direction of patients'self-paid expences,and has a well-developed dual-way communication mechanism.Conclusion:China should establish a comprehensive health insurance fund supervision pathway,clearly define the resolution pathway for self-paid expenses caused by violations,and improve the mechanisms for negotiation and dispute resolution during the process.
9.Incorporating Insights from Japan's Health Insurance Fund Regulation into China's Framework
Yuhao WANG ; Yuanyi WU ; Jieying HUANG ; Yuqi GU ; Jialong WANG ; Nana LU ; Wei XU
Chinese Health Economics 2024;43(11):91-96
Objective:To introduce the health insurance fund supervision model in Japan,compare the current situation of health insurance fund supervision in China,learn from experiences,and propose suggestions for improvement.Methods:By combining cases and regulatory effects,it introduces Japan's"guidance-inspection"based health insurance fund supervision model.Results:Japan's"guidance-inspection"based health insurance fund supervision model is relatively effective.Compared with China,it has a higher level of organizational hierarchy,focuses on education in its supervisory approach,clarifies the direction of patients'self-paid expences,and has a well-developed dual-way communication mechanism.Conclusion:China should establish a comprehensive health insurance fund supervision pathway,clearly define the resolution pathway for self-paid expenses caused by violations,and improve the mechanisms for negotiation and dispute resolution during the process.
10.Incorporating Insights from Japan's Health Insurance Fund Regulation into China's Framework
Yuhao WANG ; Yuanyi WU ; Jieying HUANG ; Yuqi GU ; Jialong WANG ; Nana LU ; Wei XU
Chinese Health Economics 2024;43(11):91-96
Objective:To introduce the health insurance fund supervision model in Japan,compare the current situation of health insurance fund supervision in China,learn from experiences,and propose suggestions for improvement.Methods:By combining cases and regulatory effects,it introduces Japan's"guidance-inspection"based health insurance fund supervision model.Results:Japan's"guidance-inspection"based health insurance fund supervision model is relatively effective.Compared with China,it has a higher level of organizational hierarchy,focuses on education in its supervisory approach,clarifies the direction of patients'self-paid expences,and has a well-developed dual-way communication mechanism.Conclusion:China should establish a comprehensive health insurance fund supervision pathway,clearly define the resolution pathway for self-paid expenses caused by violations,and improve the mechanisms for negotiation and dispute resolution during the process.

Result Analysis
Print
Save
E-mail